PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login Register FREE

MEC protocol 2

Subscribe to Selected New Research on MEC protocol 2

0 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: chemotherapy protocol consisting of above compounds; used in the treatment of bladder cancer

Bio-Agent Context: Research Results

-

Therapeutics: 5195

-

Drug Therapy: 116609

-

Combination Drug Therapy: 8322

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

-

Clinical Protocols

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 16

*

-

Inorganic Chemicals: 5

-

Platinum Compounds: 253

-

Cisplatin: 19140

*

-

Nitrogen Compounds: 35

-

Cisplatin: 19140

*

-

Chlorine Compounds: 4

-

Cisplatin: 19140

*

-

Heterocyclic Compounds: 23

-

2-Ring Heterocyclic Compounds

-

-

-

Aminopterin: 222

-

Methotrexate: 11848

*

-

Organic Chemicals: 40

-

Hydrocarbons: 382

-

Cyclic Hydrocarbons: 2

-

Aromatic Hydrocarbons: 115

-

Aromatic Polycyclic Hydrocarbons: 581

-

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

-

Polycyclic Compounds: 58

-

Aromatic Polycyclic Hydrocarbons: 581

-

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*

-

Carbohydrates: 2946

-

Glycosides: 339

-

Aminoglycosides: 1075

-

Anthracyclines: 1290

-

Daunorubicin: 1725

-

Doxorubicin: 15007

-

Epirubicin: 2010

*